| 1 |
34511889 | 10-Year Evaluation of Adherence and Satisfaction with Information about Tolvaptan in ADPKD: A Single-Center Pilot Study. | 2021 |
1 |
| 2 |
32527945 | Urinary Lithogenic Risk Profile in ADPKD Patients Treated with Tolvaptan. | 2020 Jul 1 |
1 |
| 3 |
30803403 | Impact of renal function on mid-term outcomes in heart failure patients treated with tolvaptan. | 2019 Jan-Dec |
1 |
| 4 |
29970015 | Case report: a thiazide diuretic to treat polyuria induced by tolvaptan. | 2018 Jul 3 |
1 |
| 5 |
30026287 | Long-Term Administration of Tolvaptan in Autosomal Dominant Polycystic Kidney Disease. | 2018 Aug 7 |
3 |
| 6 |
27920153 | Urine Osmolality, Response to Tolvaptan, and Outcome in Autosomal Dominant Polycystic Kidney Disease: Results from the TEMPO 3:4 Trial. | 2017 May |
2 |
| 7 |
27404673 | Prognostic impact of early treatment with tolvaptan in patients with acute heart failure and renal dysfunction. | 2016 Oct 15 |
1 |
| 8 |
29142926 | Prognostic Enrichment Design in Clinical Trials for Autosomal Dominant Polycystic Kidney Disease: The TEMPO 3:4 Clinical Trial. | 2016 Nov |
2 |